
Contact this Provider:
- Breast Medical Oncology
- atypical ductal hyperplasia
- brca
- breast cancer
- breast cancer during pregnancy
- breast cancer in young women Show All
- adjuvant chemotherapy
- breast cancer chemotherapy
- breast cancer follow up
- breast cancer genetics
- chemoradiation Show All
Julie M Collins, MD, MPH, is a fellowship-trained, board-certified medical oncologist. She specializes in diagnosing and treating all types of breast cancer (hormone receptor-positive, triple-negative, and HER2-positive) and carcinoma in situ of the breast. She offers patients advanced and highly specialized care, including chemotherapy, chemoimmunotherapy, targeted therapies, immunotherapy, endocrine therapies, and clinical trials. Dr. Collins has experience with phase I, II, and III clinical trials. Dr. Collins’ research focuses on the development of novel therapies for patients with breast cancer, specifically immunotherapies and therapies to overcome endocrine resistance.
Dr. Collins’ Philosophy of Care:
"I approach each patient from a humanistic perspective, considering not only their diagnosis but also who they are as a person. I seek to understand each patient’s goals and hopes while incorporating both standard therapies and novel approaches with an evidence-based mindset."
Conditions treated:
- All types of breast cancer (hormone receptor-positive, triple-negative, and HER2-positive)
- Early-stage breast cancer
- Metastatic breast cancer
- Carcinoma in situ of the breast
Procedures performed:
- Chemotherapy
- Chemoimmunotherapy
- Targeted therapies
- Immunotherapy
- Endocrine therapies
- Clinical trials
Area(s) of expertise:
- Breast cancer (hormone receptor-positive, triple-negative, and HER2/neu-positive)
- Carcinoma in situ of the breast
- Clinical trials
Research interests:
- Endocrine resistance-immunotherapies
- Clinical trials
- New drug development
- Fellowship Program: National Institute of Health (2019)
- Residency Program: Tulane University Medical Center (2016)
- Medical School: Tulane University (2013)
- MedStar Georgetown University Hospital
- Academic Achievement Award, National Cancer Institute, 2019
- Merit Award, Conquer Cancer Foundation of ASCO, 2019
- Travel Award, 5th Annual Immuno-Oncology Young Investigators’ Forum, 2019
- Travel Award, SITC Cancer Immunotherapy Winter School, 2019
- Academic Achievement Award, National Cancer Institute, 2018
- Merit Award, Conquer Cancer Foundation of ASCO, 2018
- AACR/ASCO Methods in Clinical Cancer Research Workshop (Vail, CO), 2018
- The Department of Medicine Chairman’s Award, Tulane University School of Medicine, 2013